Evid Invest
Who owns VORWhat VOR owns — n/a

Who owns Vor Biopharma Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of VOR from SEC Form 13F filings across 156 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 156 institutions disclosed 55.3M shares of Vor Biopharma Inc. worth $1.06B — about 92.7% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

156

13F holders

$1.06B

value, 2026 filers

92.7%

of shares outstanding (55.3M sh)

67

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of VOR's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC6.8M$129.0M0.0%11.3%+37.0%
2TCG Crossover Management, LLC5.7M$108.2M3.1%9.5%0.0%
3RA CAPITAL MANAGEMENT, L.P.4.5M$85.9M0.9%7.5%+87.5%
4FCPM III SERVICES B.V.3.4M$65.0M6.1%5.7%-17.3%
5BlackRock, Inc.3.3M$63.1M0.0%5.5%-4.7%
6Venrock Adviser, LLC3.0M$58.0M2.8%5.1%0.0%
7Frazier Life Sciences Management, L.P.2.7M$52.4M1.3%4.6%+7.9%
8VANGUARD CAPITAL MANAGEMENT LLC2.0M$38.8M0.0%3.4%-2.3%
9STATE STREET CORP2.0M$37.6M0.0%3.3%-24.7%
10Caligan Partners LP1.9M$36.7M2.2%3.2%0.0%
11GREAT POINT PARTNERS LLC1.1M$21.5M5.1%1.9%-33.7%
12MILLENNIUM MANAGEMENT LLC991,532$18.9M0.0%1.7%+131.6%
13GEODE CAPITAL MANAGEMENT, LLC979,890$18.7M0.0%1.6%-7.8%
14Nantahala Capital Management, LLC931,644$17.8M0.6%1.6%+10.3%
15Paradigm Biocapital Advisors LP889,575$17.0M0.3%1.5%-49.2%
16FEDERATED HERMES, INC.NEW760,221$14.5M0.0%1.3%new
17GOLDMAN SACHS GROUP INC746,214$14.2M0.0%1.3%+126.9%
18NAN FUNG TRINITY (HK) LTD721,550$13.8M1.3%1.2%+11.6%
19BOOTHBAY FUND MANAGEMENT, LLC646,521$12.3M0.2%1.1%+15.7%
20NEXTBio Capital Management LP620,931$11.8M5.1%1%-30.2%
21Rosalind Advisors, Inc.609,199$11.6M3.7%1%-6.1%
22UBS Group AG583,666$11.1M0.0%1%+18.3%
23MARSHALL WACE, LLP560,715$10.7M0.0%0.9%+486.3%
24Vivo Capital, LLCNEW550,358$10.5M1.2%0.9%new
25AMERIPRISE FINANCIAL INCNEW537,150$10.2M0.0%0.9%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.
EvidInvest Pro: unlimited filings data, $50/month